Mechanisms of diminished natural killer cell activity in pregnant women and neonates.
Because alterations in natural killer (NK) activity in the perinatal period may be important in the maintenance of a healthy pregnancy, we examined the mechanisms by which these alterations are mediated in neonates and in pregnant and postpartum women. NK activity, as measured in a 4-hr 51Cr-release assay and compared with adult controls, is significantly diminished in all three trimesters of pregnancy and in immediately postpartum women. In postpartum women, NK activity appears to be higher than in pregnant women, although this does not reach statistical significance. Pregnant and postpartum women have normal numbers of large granular lymphocytes and normal target cell binding in an agarose single cell assay but decreased lysis of the bound target cells. NK activity of mononuclear cells from postpartum women, in addition, demonstrate a shift in distribution to higher levels of resistance to gamma-irradiation. Further, sera from postpartum women cause a similar shift to increased radioresistance in mononuclear cells from adult controls. Because radioresistance is a property of interleukin 2-stimulated NK, the shift to radioresistance may represent lymphokine-mediated stimulation occurring during parturition. In contrast, cord blood cells have a more profound decrease in NK activity as determined by 51Cr-release assay and decreases in both binding and lysis of bound target cells in the single cell assay. The resistance of NK activity in cord cells to gamma-irradiation is also increased, as seen in postpartum women. Cord blood serum, however, did not alter radioresistance or inhibit NK activity. The results suggest that the observed diminished NK activity in pregnant women and neonates arise by different mechanisms: an absence of mature NK cells in the neonate and an alteration of the NK cell in pregnancy leading to decreased killing.
D000328:Adult; D000375:Aging; D001665:Binding Sites; D002450:Cell Communication; D002860:Chromium Radioisotopes; D003602:Cytotoxicity, Immunologic / Q000528:radiation effects; D005260:Female; D005312:Fetal Blood / Q000166:cytology; D006023:Glycoproteins / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism / Q000528:radiation effects; D007958:Leukocyte Count; D008297:Male; D009363:Neoplasm Proteins; D049590:Postpartum Period; D011247:Pregnancy
D002860:Chromium Radioisotopes; D006023:Glycoproteins; D009363:Neoplasm Proteins; C038588:serum immunosuppressive factor, human